InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Wednesday, 06/15/2016 10:55:56 AM

Wednesday, June 15, 2016 10:55:56 AM

Post# of 4867
Any thoughts on the small biotech CytoDyn disrupting Gilead's revenue stream with their drug PRO 140 that is in clinical trials. I see Charlie Sheen is going on a PR tour saying he's doing well on the drug. I was thinking about jumping in here but I'm a little reluctant. HIV drugs account for almost half of Gileads revenue.

Thoughts on this?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News